Bioventus (BVS) Current Assets (2020 - 2026)

Bioventus (BVS) has 7 years of Current Assets data on file, last reported at $249.8 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets changed 0.18% year-over-year to $249.8 million; the trailing twelve-month figure through Mar 2026 stood at $249.8 million (changed 0.18% YoY), and the FY2025 full-year result was $272.8 million, down 1.0% from the prior year.
• Current Assets for Q1 2026 stood at $249.8 million, down from $272.8 million in the prior quarter.
• Across five years, Current Assets topped out at $308.9 million in Q2 2024 and bottomed at $245.4 million in Q2 2022.
• The 5-year median for Current Assets is $272.6 million (2022), against an average of $272.4 million.
• The widest annual swing landed in 2023, when Current Assets gained 25.78%; it then retreated 13.85% in 2024.
• A 5-year view of Current Assets shows it stood at $272.6 million in 2022, then dropped by 1.68% to $268.0 million in 2023, then rose by 2.84% to $275.6 million in 2024, then dropped by 1.0% to $272.8 million in 2025, then slipped by 8.44% to $249.8 million in 2026.
• The last three Current Assets figures came in at $249.8 million (Q1 2026), $272.8 million (Q4 2025), and $280.9 million (Q3 2025), per Business Quant data.

Peer Comparison